| Classification | No. (%) of patients | |||||
|---|---|---|---|---|---|---|
| Men n = 12 748 | Women n = 28 526 | Total n = 41 274 | ||||
| Selective serotonin reuptake inhibitors | 8 291 | (65.0) | 19 756 | (69.3) | 28 047 | (68.0) |
| Atypical antipsychotics | 3 067 | (24.1) | 6 350 | (22.3) | 9 417 | (22.8) |
| Serotonin–norepinephrine reuptake inhibitors | 2 478 | (19.4) | 6 401 | (22.4) | 8 879 | (21.5) |
| Tricyclics and tetracyclics | 1 384 | (10.9) | 4 026 | (14.1) | 5 410 | (13.1) |
| Serotonin antagonist and reuptake inhibitors | 1 142 | (9.0) | 2 988 | (10.5) | 4 130 | (10.0) |
| Bipolar medications | 508 | (4.0) | 976 | (3.4) | 1 484 | (3.6) |
| Monoamine oxidase inhibitors | 43 | (0.3) | 71 | (0.3) | 114 | (0.3) |
| No depression medication | 2 222 | (17.4) | 4 083 | (14.3) | 6 305 | (15.3) |